Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
Alemtuzumab benefits hard-to-treat MS patients
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Raxone®/Catena® (idebenone)
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.

Pages